GH: Barclays Raises PT
Barclays maintains overweight rating on Guardant Health and raises price target to $150
Barclays Maintains Overweight on Guardant Health, Raises Price Target to $150
Barclays maintains overweight rating on Guardant Health and raises price target to $150
Barclays Maintains Overweight on Guardant Health, Raises Price Target to $150